Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Aug 5;14(8):16168-83.
doi: 10.3390/ijms140816168.

Post-transcriptional regulation by poly(ADP-ribosyl)ation of the RNA-binding proteins

Affiliations
Review

Post-transcriptional regulation by poly(ADP-ribosyl)ation of the RNA-binding proteins

Yingbiao Ji et al. Int J Mol Sci. .

Abstract

Gene expression is intricately regulated at the post-transcriptional level by RNA-binding proteins (RBPs) via their interactions with pre-messenger RNA (pre-mRNA) and mRNA during development. However, very little is known about the mechanism regulating RBP activities in RNA metabolism. During the past few years, a large body of evidence has suggested that many RBPs, such as heterogeneous nuclear ribonucleoproteins (hnRNPs), undergo post-translational modification through poly(ADP-ribosyl)ation to modulate RNA processing, including splicing, polyadenylation, translation, miRNA biogenesis and rRNA processing. Accordingly, RBP poly(ADP-ribosyl)ation has been shown to be involved in stress responses, stem cell differentiation and retinal morphogenesis. Here, we summarize recent advances in understanding the biological roles of RBP poly(ADP-ribosyl)ation, as controlled by Poly(ADP-ribose) Polymerases (PARPs) and Poly(ADP-ribose) Glycohydrolase (PARG). In addition, we discuss the potential of PARP and PARG inhibitors for the treatment of RBP-related human diseases, including cancer and neurodegenerative disorders.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Nuclear Poly(ADP-ribose) turnover. Level of cellular pADPr reflects relative activities of the poly(ADP-ribose) polymerase (PARP) enzyme, which utilizes NAD to create pADPr-modified proteins, and the poly(ADP-Ribose) glycohydrolase (PARG) enzyme, which removes pADPr moieties. Arrowheads indicate cleavage sites of poly(ADP-ribose) by PARG.
Figure 2
Figure 2
Model explaining the regulatory role of RNA binding proteins (RBP) poly(ADP-ribosyl)ation. (A) In a temporal- or spatial-specific way, protein poly(ADP-ribosyl)ation is reversed by PARG activity. Therefore, RBPs bind only partially to poly(ADP-ribose) and will bind to their target heterogeneous nuclear RNAs (hnRNAs) for RNA processing or translational control; (B) Once PARG activity is downregulated (high PARP-1–low PARG activities) in different tissues or developmental stages, RBPs are poly(ADP-ribosyl)ated, which inhibits RBPs from binding to hnRNAs. Therefore, the hnRNA transcripts are not processed or translated, and developmental patterns are changed; (C) Downregulation of PARP-1 (low PARP-1–high PARG activities) leads to depletion of poly(ADP-ribose). Thus, all RBPs excessively bind to hnRNAs, altering processing and translation.
Figure 3
Figure 3
Diagram illustrating how hnRNP poly(ADP-ribosyl)ation controls maintenance of stem cells in the stem cell niche. HnRNP poly(ADP-ribosyl)ation regulates E-cadherin (E-Cad) translation: hnRNP binds to 5′UTR of E-cadherin to promote translation. Once hnRNP is poly(ADP-ribosyl)ated and dissociated from 5′UTR of E-cadherin, its translation is inhibited; Poly(ADP-ribosyl)ation of hnRNP controls germline stem cell maintenance: E-cadherin protein (red) accumulates between stem cell niche cells (Cap Cell) and stem cells, keeping stem cells in the niche. High level of poly(ADP-ribosyl)ation during mitosis and in cystoblasts suppresses translation of E-cadherin. Suppression of E-cadherin production promotes cystoblasts that have not established contacts with cap cells to leave the stem cell niche and differentiate.

Similar articles

Cited by

References

    1. Houseley J., Tollervey D. The many pathways of RNA degradation. Cell. 2009;136:763–776. - PubMed
    1. Keene J.D. RNA regulons: Coordination of post-transcriptional events. Nat. Rev. Genet. 2007;8:533–543. - PubMed
    1. Licatalosi D.D., Darnell R.B. RNA processing and its regulation: Global insights into biological networks. Nat. Rev. Genet. 2010;11:75–87. - PMC - PubMed
    1. Änkö M.-L., Neugebauer K.M. RNA-protein interactions in vivo: Global gets specific. Trends Biochem. Sci. 2012;37:255–262. - PubMed
    1. Lukong K.E., Chang K.W., Khandjian E.W., Richard S. RNA-binding proteins in human genetic disease. Trends Genet. 2008;24:416–425. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources